I agree that this site is using cookies. You can find further informations here.
X
Samira Elbai
6  results:
Search for persons X
?
1

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Moore, Gillian ; Lightner, Clara ; Elbai, Samira...
Cancers.  13 (2021)  9 - p. 2139 , 2021
Link: https://doi.org/10.3390/..
 
?
2

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Gillian Moore ; Clara Lightner ; Samira Elbai...
Cancer Therapy.  , 2021
Link: https://doi.org/10.3390/..
 
?
3

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Gillian Moore ; Clara Lightner ; Samira Elbai...
https://www.mdpi.com/2072-6694/13/9/2139.  , 2021
Link: https://doi.org/10.3390/..
 
?
4

Co-targeting PIM kinase and PI3K/mTOR in NSCLC:

Moore, Gillian ; Lightner, Clara ; Elbai, Samira...
https://eprints.qut.edu.au/233047/1/111969870.pdf.  , 2021
Link: https://eprints.qut.edu...
 
?
5

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC:

Moore, Gillian ; Lightner, Clara ; Elbai, Samira...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125027/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

In-depth profiling of drug resistance to PI3K-mTOR inhibiti..:

Elbai, Samira Mohamed
Elbai, Samira Mohamed, In-depth profiling of drug resistance to PI3K-mTOR inhibition and intra-tumour heterogeneity in NSCLC, Trinity College Dublin.School of Medicine, 2021.  , 2021
Link: http://hdl.handle.net/22..
 
1-6